RedChip Companies aired interviews with Atossa Therapeutics, Inc. (Nasdaq:ATOS) and Ainos, Inc. (Nasdaq:AIMD) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, on May ...

Expanding accessibility to early detection would improve treatment outcomes, reduce mortality, and minimized the emotional ...

The former RTE mid-west correspondent, who retired last week, has revealed that she received a cancer diagnosis last year ...

Traditional drug delivery systems send a vague package through the body that requires higher doses than necessary and might harm organs in the process of trying to find their destination.

Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations.

From May 5-8, more than 1,800 health care professionals and volunteers will converge at America's Center in downtown to provide free medical, dental, and vision care for up to 1,200 people per day.